Evidence map›Paper›PMID 24889605›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Differential role of nonhomologous end joining factors in the generation, DNA damage response, and myeloid differentiation of human induced pluripotent stem cells.

Kerstin Felgentreff, Likun Du, Katja G Weinacht, Kerry Dobbs, Margarita Bartish, Silvia Giliani, Thorsten Schlaeger, Alexander DeVine, Axel Schambach, Lisa J Woodbine and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Aging · 2020
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 6 countries.

Kerstin FelgentreffDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115;
Likun DuDivision of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, SE 14186 Stockholm, Sweden;
Katja G WeinachtDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115;Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, MA 02115;
Kerry DobbsDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115;
Margarita BartishDivision of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, SE 14186 Stockholm, Sweden;
Silvia GilianiA. Nocivelli Institute for Molecular Medicine, Pediatric Clinic, University of Brescia, Spedali Civili, 25123 Brescia, Italy;
Thorsten SchlaegerDivision of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, MA 02115;
Alexander DeVineDivision of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, MA 02115;
Axel SchambachDivision of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, MA 02115;Institute of Experimental Hematology, Hannover Medical School, D-30625 Hannover, Germany;
Lisa J WoodbineGenome Damage and Stability Centre, University of Sussex, Brighton BN1 9RQ, United Kingdom;
Graham DaviesCentre for Immunodeficiency, Great Ormond Street Hospital and Institute of Child Health, London WC1N 3JH, United Kingdom;
Sachin N BaxiDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115;
Mirjam van der BurgDepartment of Immunology, Erasmus Medical Center, 3015 GE, Rotterdam, The Netherlands;
Jack BleesingDivision of Bone Marrow Transplant and Immunodeficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229;
Andrew GenneryInstitute of Cellular Medicine, Pediatric Immunology, University of Newcastle-upon-Tyne, Newcastle-upon-Tyne NE1 4LP, United Kingdom;
John ManisDepartment of Transfusion Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115; and.
Qiang Pan-HammarströmDivision of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, SE 14186 Stockholm, Sweden;
Luigi D NotarangeloDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115;Harvard Stem Cell Institute, Cambridge, MA 02138 Luigi.Notarangelo@childrens.harvard.edu.
Boston Children's Hospital · USHarvard University · USKarolinska Institutet · SECincinnati Children's Hospital Medical Center · USErasmus MC · NLInstitute for Molecular Medicine · USKarolinska University Hospital · SEMedizinische Hochschule Hannover · DENewcastle University · GBUniversity College London · GBUniversity of Sussex · GB

Funding

Role of TACI mutations in CVIDP01AI076210 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TERHORST, CORNELIS P · 2009 to 2013
$9.0M
Modeling and correcting human SCID using patient-derived iPS cellsR01AI100887 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI MANIS, JOHN P · 2012 to 2020
$4.5M
European Research Council 242551NIAID NIH HHS 1R01AI100887NIAID NIH HHS 5P01AI076210-04NIAID NIH HHS P01 AI076210NIAID NIH HHS R01 AI100887
6 · The paper itself

Abstract

Nonhomologous end-joining (NHEJ) is a key pathway for efficient repair of DNA double-strand breaks (DSBs) and V(D)J recombination. NHEJ defects in humans cause immunodeficiency and increased cellular sensitivity to ionizing irradiation (IR) and are variably associated with growth retardation, microcephaly, and neurodevelopmental delay. Repair of DNA DSBs is important for reprogramming of somatic cells into induced pluripotent stem cells (iPSCs). To compare the specific contribution of DNA ligase 4 (LIG4), Artemis, and DNA-protein kinase catalytic subunit (PKcs) in this process and to gain insights into phenotypic variability associated with these disorders, we reprogrammed patient-derived fibroblast cell lines with NHEJ defects. Deficiencies of LIG4 and of DNA-PK catalytic activity, but not Artemis deficiency, were associated with markedly reduced reprogramming efficiency, which could be partially rescued by genetic complementation. Moreover, we identified increased genomic instability in LIG4-deficient iPSCs. Cell cycle synchronization revealed a severe defect of DNA repair and a G0/G1 cell cycle arrest, particularly in LIG4- and DNA-PK catalytically deficient iPSCs. Impaired myeloid differentiation was observed in LIG4-, but not Artemis- or DNA-PK-mutated iPSCs. These results indicate a critical importance of the NHEJ pathway for somatic cell reprogramming, with a major role for LIG4 and DNA-PKcs and a minor, if any, for Artemis.

Indexed as

DNA Breaks, Double-StrandedDNA End-Joining RepairCatalysisCell CycleCell DifferentiationCell LineCell LineageDNA-Activated Protein KinaseDNA-Binding ProteinsDNA Ligase ATPDNA LigasesEndonucleasesFibroblastsHematopoietic Stem CellsHumansInduced Pluripotent Stem CellsDCLRE1C protein, humanDNA-Activated Protein KinaseDNA-Binding ProteinsDNA Ligase ATPDNA LigasesEndonucleasesLIG4 protein, humanNuclear Proteins

Identifiers

PMID24889605
PMCPMC4066476
OpenAlexW2171691529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.